Institutional Ownership Edwards Lifesciences Corp (EW)
This table provides information about the institutional ownership of Edwards Lifesciences Corp (EW). We have compiled data on the 1,351 institutions that hold shares in the stock, with a total of 455 Million shares, which have been reported (via 13F filing form) to have a value of $30.9 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
62,594,542
shares
|
$4.24 Billion
0.08% of portfolio
|
Q3 2024
Added 16.83%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
50,975,492
shares
|
$3.45 Billion
0.11% of portfolio
|
Q2 2024
Reduced 2.75%
|
|
Wellington Management Group LLP
Boston, MA |
Nov 14, 2024 Q3 2024 |
31,532,725
shares
|
$2.14 Billion
0.37% of portfolio
|
Q3 2024
Added 86.33%
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
26,265,633
shares
|
$1.78 Billion
0.07% of portfolio
|
Q3 2024
Added 0.99%
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
13,521,147
shares
|
$916 Million
0.07% of portfolio
|
Q3 2024
Added 2.15%
|
|
Ken Fisher
Fisher Asset Management, LLC | Camas, Wa
|
Nov 12, 2024 Q3 2024 |
9,078,311
shares
|
$615 Million
0.25% of portfolio
|
Q3 2024
Added 9.75%
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 08, 2024 Q3 2024 |
8,466,048
shares
|
$574 Million
0.05% of portfolio
|
Q3 2024
Reduced 1.8%
|
|
Brown Advisory Inc
|
Nov 13, 2024 Q3 2024 |
7,579,656
shares
|
$514 Million
0.65% of portfolio
|
Q3 2024
Reduced 54.21%
|
|
Ninety One Uk LTD
London, X0 |
Nov 12, 2024 Q3 2024 |
7,311,728
shares
|
$495 Million
1.34% of portfolio
|
Q3 2024
Added 1658.65%
|
|
Alliancebernstein L.P.
New York, NY |
Nov 14, 2024 Q3 2024 |
6,983,259
shares
|
$473 Million
0.16% of portfolio
|
Q3 2024
Reduced 65.67%
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Nov 13, 2024 Q3 2024 |
6,250,279
shares
|
$424 Million
0.17% of portfolio
|
Q3 2024
Added 68.89%
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Nov 14, 2024 Q3 2024 |
6,005,789
shares
|
$407 Million
0.1% of portfolio
|
Q3 2024
Added 1.03%
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
5,720,762
shares
|
$388 Million
0.03% of portfolio
|
Q3 2024
Reduced 12.67%
|
|
Legal & General Group PLC
London, X0 |
Nov 14, 2024 Q3 2024 |
5,355,811
shares
|
$363 Million
0.08% of portfolio
|
Q3 2024
Reduced 0.63%
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
5,339,382
shares
|
$362 Million
0.06% of portfolio
|
Q3 2024
Reduced 6.59%
|
|
Sands Capital Management, LLC
Arlington, VA |
Nov 13, 2024 Q3 2024 |
5,338,095
shares
|
$362 Million
1.12% of portfolio
|
Q3 2024
Reduced 5.5%
|
|
Wellcome Trust LTD (The) As Trustee Of The Wellcome Trust
|
Oct 21, 2024 Q3 2024 |
4,500,000
shares
|
$305 Million
3.96% of portfolio
|
Q3 2024
Added 9.76%
|
|
Marshall Wace, LLP
London, X0 |
Nov 14, 2024 Q3 2024 |
3,733,777
shares
|
$253 Million
0.32% of portfolio
|
Q3 2024
Added 4900.64%
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Nov 14, 2024 Q3 2024 |
3,693,663
shares
|
$250 Million
0.99% of portfolio
|
Q3 2024
Added 239.89%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
3,659,102
shares
|
$248 Million
0.05% of portfolio
|
Q3 2024
Added 1.47%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
3,541,783
shares
|
$240 Million
0.03% of portfolio
|
Q3 2024
Reduced 51.72%
|
|
Amundi
Paris, I0 |
Nov 13, 2024 Q3 2024 |
3,482,408
shares
|
$236 Million
0.09% of portfolio
|
Q3 2024
Reduced 33.26%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
3,386,489
shares
|
$229 Million
0.06% of portfolio
|
Q3 2024
Added 10.9%
|
|
Australian Super Pty LTD
|
Oct 28, 2024 Q3 2024 |
3,273,416
shares
|
$222 Million
1.1% of portfolio
|
Q3 2024
Added 17.8%
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
3,214,177
shares
|
$218 Million
0.04% of portfolio
|
Q3 2024
Reduced 19.73%
|